Article Menu

Export Article

EndNote (RIS)
BibTeX
RefMan
RefWorks

Article Data

Views 206
Dowloads 139

Case Reports

Open Access

Recurrent endometrial stromal sarcoma after treatment with high-dose chemotherapy and autologous stem-cell support: A case report

P. Klaritsch¹
O. Reich^1,*,
S. Regauer²
T. Bauernhofer³

¹Departments of Obstetrics and Gynecology, Medical University of Graz, Austria

²Departments of Pathology, Medical University of Graz, Austria

³Departments of Medical Oncology, Medical University of Graz, Austria

DOI: 10.12892/ejgo200603297 Vol.27,Issue 3,May 2006 pp.297-298

Published: 10 May 2006

*Corresponding Author(s): O. Reich E-mail:

PDF (182.37 kB)

Abstract

Introduction: The efficacy of high-dose chemotherapy plus transplantation of autologous hematopoetic stem cells in patients with endometrial stromal sarcomas is unknown.

Case report: A 39-year-old woman with Stage III endometrial stromal sarcoma (ESS) underwent radical surgery, followed by five courses of ifosfamide, adriamycin and dacarbazine postoperatively. Six months after primary surgery stem cell priming was performed. Five months later bone marrow was aspirated and high-dose chemotherapy with carboplatin, vepeside and holoxan were administered after which bone marrow was retransfused. Seven years after primary surgery the patient developed an abdominal recurrence which was removed surgically and adjuvant radiotherapy was administered. One year later the patient underwent hemicolectomy because of a new recurrence infiltrating the ascending colon. Treatment with 25 mg exemestane was begun. The patient is currently alive and free of disease nine years after the initial diagnosis.

Conclusion: Aggressive chemotherapy with autologous stem-cell support seems to be ineffective in patients with ESS.

Keywords

Endometrial stromal sarcoma; Treatment; High-dose chemotherapy; Stem-cell support

Cite and Share

P. Klaritsch,O. Reich,S. Regauer,T. Bauernhofer. Recurrent endometrial stromal sarcoma after treatment with high-dose chemotherapy and autologous stem-cell support: A case report . European Journal of Gynaecological Oncology. 2006. 27(3);297-298.

URL:

https://www.ejgo.net/articles/10.12892/ejgo200603297

References

[1] Gadducci A., Sartori E., Landoni F., Zola P., Maggino T., Urgesi A. et al.: "Endometrial stromal sarcoma: Analysis of treatment failures and survival". Gynecol. Oneal., 1996, 63, 247.

[2] Piver M.S., Rutledge F.N., Copeland L., Webster K., Blumenson L., Suh O.: "Uterine endolymphatic stromal myosis: a collaborative study". Obstet. Gynecol., 1984, 64, 173.

[3] Berchuck A., Rubin S.C., Hoskins W.J., Saigo P.E., Pierce V.K., Lewis J.L. Jr.: "T reatment of endometrial stromal tumors". Gynecol. Oneal., 1990, 36, 60.

[4] Sutton G., Blessing J.A., Park R., DiSaia P.J., Rosenshein N.: "Ifosfamide treatment of recurrent or metastatic endometrial stromal sarcomas previously unexposed to chemotherapy: a study of the Gynecologic Oncology Group". Obstet. Gynecol., 1996, 87, 747.

[5] El Husseiny G., Al Bareedy N., Mourad W.A., Mohamed G., Shoukri M., Subhi J., Ezzat A.: "Prognostic factors and treatment modalities in uterine sarcoma". Am. J. Clin. Oneal., 2002, 25, 256.

[6] Lehmer L.M., Miles P.A., Enck R.E.: "Complete remission of widely metastatic endometrial stromal sarcoma following combination chemotherapy". Cancer, 1979, 43, 1189.

[7] Reich O., Regauer S.: "Aromatase expression in low-grade endometrial stromal sacromas: an immunohistochemical study". Mod. Path., 2004, 17, 104.

[8] Reich O., Regauer S.: "Gonadotropin-releasing hormone receptor expression in endometrial stromal sarcomas: an immunohistochemical study". Mod. Path., 2005, 18, 573.

Current Issue

Vol., Issue , Invalid date

Table of contents
All Issues

Submit to EJGO Review for EJGO Edit a Special Issue

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top